🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Announcing our next IG Live! 🎉 Featuring Jeremy Faust MD MS (ER physician), Arghavan Salles, MD, PhD, & Shikha Jain MD, FACP, this live discussion will focus on strategies to advance gender equity in the field of medicine. Tune in on March 17 at 2pm ET! To join, follow us on IG: bit.ly/3T0kK9U @WIMSummit

Teenagers' bad sleep habits are linked to insulin resistance. onlinelibrary.wiley.com/doi/full/10.10…

Very excited to share our op-ed on the importance of medical treatment for gender nonconforming youth using a patient-centered approach without political influence ⁦MedPage Today⁩ ⁦Genevieve Friedman⁩ ⁦NYC Health + Hospitals⁩ ⁦NYC Health + Hospitals/South Brooklyn Health⁩ medpagetoday.com/opinion/second…

🔥tip: GLP1s can affect absorption of other #medications eg) Rybelsus ↑ levothyroxine absorption by 33% If your patient is experiencing new side effects that you can't attribute directly to the GLP1, they might be absorbing more of their other medications #medicine #endocrine

Sleep deprivation causes weight gain by lowering #leptin and raising #ghrelin levels. onlinelibrary.wiley.com/doi/10.1002/ob…

Does #Wegovy Shrink Muscle Mass to a concerning degree as raised by Peter Attia recently? medpagetoday.com/special-report… Check out our comments in this MedPage Today article

In patients with NASH cirrhosis, #semaglutide did not significantly improve fibrosis or #NASH resolution vs. placebo. However, semaglutide improves metabolic syndrome, BMI, liver enzymes, and hepatic steatosis, but not liver stiffness. Rohit Loomba thelancet.com/journals/langa…

"We shouldn't be scaring away people who have obesity and obesity-related complications." -- Karl Nadolsky commenting on new concerns about muscle loss for patients on #semaglutide (#Wegovy, #Ozempic). medpagetoday.com/special-report… MedPage Endocrinology Kristina Fiore

New #obesity drug has less weight loss and more side effects. But in a growing marketplace - the right price point may make it an option for some patients Altimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutide | Seeking Alpha seekingalpha.com/news/3949389-a…

When patients enroll in #clinicaltrials, they reasonably assume that the research results will be shared with the public, physicians, and fellow patients. But without FDA enforcement, that's not always the case. See our piece in MedPage Today: medpagetoday.com/opinion/second…

Obesity Tied to Density of Food Stores Carrying Less Healthy Options, Report Finds — Link between obesity and unhealthy food establishments holds in both rural and non-rural areas medpagetoday.com/endocrinology/… By Joyce Frieden MedPage Today Urban Institute Dr. Elaine Waxman

Thank you MedPage Today for covering our work that shows an association between metformin use and a reduced incidence of osteoarthritis. medpagetoday.com/primarycare/di…

‼️Our transplant surgeons wrote, "Attacking our complex and nuanced organ transplant system without realistic solutions only diverts time and resources from this lifesaving work" in the story that was published by MedPage Today ➡️ tinyurl.com/3m7whcmj 👇👇

The cardiovascular era for GLP-1RA started with preclinical data, then was launched by LEADER in 2016 and 7 subsequent CVOTs. How and where does GLP-1 produce a CV benefit? Some thoughts #CVD #T2D #diabetes #Heartdisease #Atherosclerosis Nature Reviews Cardiology nature.com/articles/s4156…

Effects of #dapagliflozin on #hospitalisations in people with type 2 #diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial thelancet.com/journals/landi… #T2D

Evidence is building that #COVID could be a risk factor for developing #diabetes, both type 1 and type 2. Rifka Schulman-Rosenbaum, MD, FACE, FACP MedPage Infectious Disease MedPage Endocrinology bit.ly/3Kn2NAW

All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains

"I get up every morning and I look at patient messages and half of them are due to #Mounjaro." -- Karl Nadolsky, of Holland Hospital, on the shortage of the #diabetes drug #tirzepatide. medpagetoday.com/special-report… MedPage Endocrinology Sophie Putka

"The study doesn't actually give a stamp of approval to run off and take testosterone." -- Bradley Anawalt, MD, commenting on the results of the #TRAVERSE trial presented at #ENDO2023. MedPage Endocrinology MedPage Cardio medpagetoday.com/meetingcoverag…

"This is exciting and a novelty for human medicine." -- Martin Wabitsch, MD, PhD, of Universität Ulm, on the success of high-dose leptin treatment on reversing severe, early-onset #obesity in two children carrying rare genetic variants. MedPage Endocrinology medpagetoday.com/pediatrics/obe…